P&K Skin Research Center Co., Ltd. (KOSDAQ: 347740)

P&K Skin Research Center Statistics

Total Valuation

P&K Skin Research Center has a market cap or net worth of KRW 61.81 billion. The enterprise value is 17.66 billion.

Market Cap	61.81B
Enterprise Value	17.66B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

P&K Skin Research Center has 28.88 million shares outstanding. The number of shares has decreased by -2.26% in one year.

Current Share Class	n/a
Shares Outstanding	28.88M
Shares Change (YoY)	-2.26%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	3.63%
Owned by Institutions (%)	n/a
Float	11.05M

Valuation Ratios

The trailing PE ratio is 9.27.

PE Ratio	9.27
Forward PE	n/a
PS Ratio	3.55
PB Ratio	0.81
P/TBV Ratio	0.82
P/FCF Ratio	7.42
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.82, with an EV/FCF ratio of 2.12.

EV / Earnings	2.61
EV / Sales	1.00
EV / EBITDA	3.82
EV / EBIT	6.33
EV / FCF	2.12

Financial Position

The company has a current ratio of 12.46, with a Debt / Equity ratio of 0.00.

Current Ratio	12.46
Quick Ratio	11.20
Debt / Equity	0.00
Debt / EBITDA	0.08
Debt / FCF	0.04
Interest Coverage	100.84

Financial Efficiency

Return on equity (ROE) is 8.94% and return on invested capital (ROIC) is 2.33%.

Return on Equity (ROE)	8.94%
Return on Assets (ROA)	2.23%
Return on Capital (ROIC)	2.33%
Revenue Per Employee	190.01M
Profits Per Employee	72.72M
Employee Count	93
Asset Turnover	0.23
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.75% in the last 52 weeks. The beta is 0.68, so P&K Skin Research Center's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	-15.75%
50-Day Moving Average	2,141.14
200-Day Moving Average	2,617.99
Relative Strength Index (RSI)	45.73
Average Volume (20 Days)	23,449

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, P&K Skin Research Center had revenue of KRW 17.67 billion and earned 6.76 billion in profits. Earnings per share was 230.84.

Revenue	17.67B
Gross Profit	8.59B
Operating Income	2.79B
Pretax Income	7.93B
Net Income	6.76B
EBITDA	4.62B
EBIT	2.79B
Earnings Per Share (EPS)	230.84

Balance Sheet

The company has 44.46 billion in cash and 366.12 million in debt, giving a net cash position of 44.09 billion or 1,526.66 per share.

Cash & Cash Equivalents	44.46B
Total Debt	366.12M
Net Cash	44.09B
Net Cash Per Share	1,526.66
Equity (Book Value)	75.79B
Book Value Per Share	2,626.24
Working Capital	47.95B

Cash Flow

In the last 12 months, operating cash flow was 9.01 billion and capital expenditures -672.77 million, giving a free cash flow of 8.34 billion.

Operating Cash Flow	9.01B
Capital Expenditures	-672.77M
Free Cash Flow	8.34B
FCF Per Share	288.60

Margins

Gross margin is 48.59%, with operating and profit margins of 15.78% and 38.27%.

Gross Margin	48.59%
Operating Margin	15.78%
Pretax Margin	44.88%
Profit Margin	38.27%
EBITDA Margin	26.17%
EBIT Margin	15.78%
FCF Margin	47.17%

Dividends & Yields

This stock pays an annual dividend of 30.00, which amounts to a dividend yield of 1.37%.

Dividend Per Share	30.00
Dividend Yield	1.37%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	10.57%
Buyback Yield	2.26%
Shareholder Yield	3.64%
Earnings Yield	10.79%
FCF Yield	13.49%

Stock Splits

The last stock split was on July 26, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jul 26, 2022
Split Type	Forward
Split Ratio	4

Scores

P&K Skin Research Center has an Altman Z-Score of 12.24.

Altman Z-Score	12.24
Piotroski F-Score	n/a